Articles tagged with Tropical Diseases
A recent study suggests that controlling neglected tropical diseases like leprosy and sleeping sickness may help combat the global fight against HIV/AIDS, tuberculosis, and malaria. Integrating these efforts could provide a cost-effective solution to control or eliminate seven neglected tropical diseases for just $200 million annually.
Researchers are exploring possible links between biting water insects, water quality, and Buruli ulcer transmission, with the goal of understanding the disease's transmission. The study aims to identify potential insect vectors and man-made changes in water quality that may be contributing to the increase in Buruli ulcer infections.
A rapid impact package of four anti-parasitic drugs could bring tangible benefits to Africa's poorest communities by controlling seven neglected diseases. The cost of the package would be negligible, ranging from $0.07 to $0.40 per person per year.
Researchers have discovered a promising new treatment for chronic Chagas disease, with one compound showing significantly greater effectiveness than current standard care. TAK-187 prevents the parasite from producing essential ergosterol, reducing cardiac and skeletal damage without toxic side effects.
UGA's Center for Tropical and Emerging Global Diseases has received a grant to train Brazilian scientists in bioinformatics, aiming to combat tropical diseases such as schistosomiasis. The program will support the development of analysis infrastructure and provide opportunities for trainees to work with NIH-funded studies.
Researchers found a specific region in the fly's gut wall where the parasite attaches and feeds on nutrients. This unique structure enables the parasite to survive and multiply within the insect host.
The partnership aims to enhance Peruvian research capacity in biomedical research, including lab-based and fieldwork. The project will cover research ethics, health economics, and train local researchers, physicians, biologists, nurses, and students.
The editorial critiques tropical medicine's focus on external solutions, emphasizing the importance of local voices and transparent research. It highlights concerns about undemocratic supranational agencies and corporations, as well as the need to put research at the heart of policy development.
The Bill & Melinda Gates Foundation has awarded a $15.11 million grant to researchers developing new drugs for African sleeping sickness and leishmaniasis. The five-year project aims to create a world-class academic and scientific consortium to target these two parasitic diseases, which kill millions of people in developing nations.